You really hit the nail on the head with that ques

You really hit the nail on the head with that question, and sometimes NP is quite unclear in what exactly he is saying, which I think can SOMETIMES be the language barrier a bit. An SAE, in my understanding, should only be in connection with leronlimab, not a placebo, unless death itself is considered in SAE no matter what meds someone is on or if they were practically dead to begin with when they got either leronlimab or placebo.